Orientia tsutsugamushi in eschars from scrub typhus patients.To verify the value of eschars for the diagnosis of scrub typhus and to characterize genotypes of Orientia tsutsugamushi in patients, we examined eschars and blood specimens of 7 patients from Shandong Province, People's Republic of China, for O. tsutsugamushi by polymerase chain reaction polymerase chain reaction (pŏl`ĭmərās') (PCR), laboratory process in which a particular DNA segment from a mixture of DNA chains is rapidly replicated, producing a large, readily analyzed sample of a piece of DNA; the process is targeting the Sta56 gene. All 7 eschars and acute-phase blood samples were positive, while no specific DNA DNA: see nucleic acid. DNA or deoxyribonucleic acid One of two types of nucleic acid (the other is RNA); a complex organic compound found in all living cells and many viruses. It is the chemical substance of genes. amplicons were obtained from the 7 convalescent-phase blood samples collected after antimicrobial drug therapy. The findings indicate that patients' eschars can be used for detection and genetic characterization of O. tsutsugamushi during the convalescent con·va·les·cent adj. Relating to convalescence. n. A person who is recovering from an illness, an injury, or a surgical operation. convalescent 1. pertaining to or characterized by convalescence. 2. phase. ********** Scrub typhus, a widely endemic disease in Asian Pacific regions, is caused by Orientia tsutsugamushi, a gram-negative obligate obligate /ob·li·gate/ (ob´li-gat) pertaining to or characterized by the ability to survive only in a particular environment or to assume only a particular role, as an obligate anaerobe. intracellular bacterium in the family Rickettsiaceae. When the rickettsia rickettsia (rĭkĕt`sēə), any of a group of very small microorganisms, many disease-causing, that live in vertebrates and are transmitted by bloodsucking parasitic arthropods such as fleas, lice (see louse), and ticks. is transmitted to a human through the bite of an infected mite, it begins to multiply at the bite site, and a characteristic skin lesion known as an eschar eschar /es·char/ (es´kahr) 1. a slough produced by a thermal burn, by a corrosive application, or by gangrene. 2. tache noire. es·char n. is formed. The pathogen then spreads systemically by the hematogenous hematogenous /he·ma·tog·e·nous/ (he?mah-toj´e-nus) 1. produced by or derived from the blood. 2. disseminated through the blood stream. he·ma·tog·e·nous adj. 1. and lymphogenous routes. Various clinical manifestations develop, including fever, rash, and lymphadenopathy lymphadenopathy /lym·phad·e·nop·a·thy/ (-op´ah-the) disease of the lymph nodes. angioimmunoblastic lymphadenopathy , angioimmunoblastic lymphadenopathy with dysproteinemia (1). Before 1986, scrub typhus was only found in southern China (south of the Yangtze River) primarily in the summer. O. tsutsugamushi, which causes "summer-type scrub typhus," is highly virulent and usually transmitted by the Leptotrombidium deliense mite. In 1986, scrub typhus was first reported in Mengyin County, Shandong Province, north of the Yangtze River. This newly recognized "autumn-winter type scrub typhus" is caused by a less virulent strain of O. tsutsugamushi and transmitted by the L. scutellare mite (1,2). Since then, cases of autumn-winter scrub typhus have been increasingly reported in many northern areas of China; eschars developed in 82%-91% of those infected (1,2). Traditionally, the diagnosis of scrub typhus mainly relied on serologic tests. The disease could be retrospectively diagnosed in cases of seroconversion seroconversion /se·ro·con·ver·sion/ (-con-ver´zhun) the change of a seronegative test from negative to positive, indicating the development of antibodies in response to immunization or infection. or a [greater than or equal to] 4-fold rise in antibody titers between acute-phase and convalescent-phase serum specimens. The requirement of double serum specimens has limited its usage for diagnosis. Recently a polymerase chain reaction (PCR PCR polymerase chain reaction. PCR abbr. polymerase chain reaction Polymerase chain reaction (PCR) ) assay was developed for detecting O. tsutsugamushi Sta56 gene in blood samples or isolates from patients (3-8). However, the test often gave a false-negative result because hemoglobin and other components in blood may inhibit PCR amplification (3,4,9). The commonly seen eschars in scrub typhus patients were suggested as alternative specimens for diagnosis (9). The objectives of this study were to verify the value of eschars for the diagnosis of scrub typhus by PCR assay and to characterize the genotype of O. tsutsugamushi during the convalescent phase. Materials and Methods Sample Collection Seven scrub typhus patients reported at Feixian County (116[degrees] 11'-118[degrees] 18'E, 35[degrees]01'-35[degrees] 33'N), Shandong Province, China, in September, October, and November of 2003-2004 were included in the study. The identification (ID) codes, age, sex, the locations of eschars, and other clinical characteristics on admission were documented (Table). The typical eschars of 2 patients (03PE1 and 04PE5) are shown in the Figure. After informed consent was obtained, 5 mL acute-phase blood was collected from each patient before treatment. Chloramphenicol chloramphenicol (klōr'ămfĕn`əkŏl'), antibiotic effective against a wide range of gram-negative and gram-positive bacteria (see Gram's stain). It was originally isolated from a species of Streptomyces bacteria. was then administered orally at a dosage of 1.5-2.5 g 4x/day for 4-5 days. Fever resolved for all 7 patients within 2 days of treatment. Eschar specimens and 5-mL convalescent-phase blood sample from each patient were collected at the time that the eschar spontaneously desquamated (6-15 days after treatment). Serum specimens were separated by centrifugation at 2,500x g for 10 min. All specimens from eschars, serum, and residual blood clots were kept at -70[degrees]C until use. [FIGURE OMITTED] Detection of IgG Antibodies against O. tsutsugamushi An indirect immunofluorescent immunofluorescent having the characteristic of immunofluorescence. immunofluorescent antibody test see fluorescence microscopy. immunofluorescent microscopy see fluorescence microscopy. antibody assay (IFA Immunofluorescent assay (IFA) A blood test sometimes used to confirm ELISA results instead of using the Western blotting. In an IFA test, HIV antigen is mixed with a fluorescent compound and then with a sample of the patient's blood. ) was performed as described previously (10), by using mixed Gilliam, Karp, and Kato strains of O. tsutsugamushi as diagnostic antigen. Scrub typhus was diagnosed in the case of seroconversion or a [greater than or equal to] 4-fold rise in IgG antibody titers between acute-phase and convalescent-phase sera. DNA Extraction Complete eschars (30-60 mg in weight) or 0.3 mL blood clot was homogenized ho·mog·e·nize v. ho·mog·e·nized, ho·mog·e·niz·ing, ho·mog·e·niz·es v.tr. 1. To make homogeneous. 2. a. To reduce to particles and disperse throughout a fluid. b. with TE (10 mmol/L Tris Cl [pH 8.0] and 1 mmol/L EDTA EDTA: see chelating agents. ) buffer and centrifuged at 3,000x g for 5 min; the supernatant was discarded. For the blood clot, the precipitate was resuspended and washed with TE buffer 3 times to eliminate the residual inhibitors in blood. Then 400 [micro]L lysis buffer (10 mmol/L Tris [pH 8.0], 0.1 mol/L EDTA, 0.5% sodium dodecyl sulfate Sodium dodecyl sulfate (or sulphate) (SDS or NaDS) (C12H25NaO4S),is an anionic surfactant that is used in household products such as toothpastes, shampoos, shaving foams and bubble baths for its thickening effect and its ability to ), 10 [micro]L proteinase proteinase /pro·tein·ase/ (pro´ten-as?) endopeptidase. pro·tein·ase n. A protease that begins the hydrolytic breakdown of proteins usually by splitting them into polypeptide chains. K (20 mg/mL; Promega Corp., Madison, WI, USA), and 2 [micro]L lysozyme lysozyme: see immunity. Lysozyme An enyme that was first identified and named by Alexander Fleming, who recognized its bacteriolytic properties. (4 mg/mL; DingGuo Biotech. Co. Ltd, Beijing, People's Republic of China) were added, and incubated at 50[degrees]C for 6 h. DNA was extracted with phenol/chloroform/isoamylalcohol (25: 24:1) and precipitated in ethanol. Finally, the DNA was washed with 75% ethanol and dissolved in 20 [micro]L distilled water. PCR Amplification PCR amplification of the Sta56 gene was performed by using species-specific primers, Pr1 (5'-tac att agc tgc agg tat gac-3') and Pr2 (5'-AAT TCT TCT The Capital Times (Madison, WI newspaper) TCT Transcatheter Cardiovascular Therapeutics TCT The Coroner's Toolkit TCT Trans Canada Trail TCT Tcl Core Team TCT Tsukuba College of Technology (Japan) TCA TCA 1. trichloroacetic acid. 2. tricarboxylic acid cycle (Krebs cycle). TCA Tricyclic antidepressant, see there ACC See adaptive cruise control. AAG AAG Association of American Geographers (Washington, DC) AAG Assistant Attorney General AAG Asociación Argentina de Golf AAG Anti-Aircraft Gun AAG Assistant Adjutant General AAG Australian Association of Gerontology CGA (Color/Graphics Adapter) The first video display standard for the IBM PC. This low-resolution system was superseded by EGA and then VGA. CGA required a digital RGB Color Display monitor. See PC display modes. CGA - Color Graphics Adapter TCC-3') (3,4,10). The amplifications were performed in a volume of 50 [micro]L with a Perkin-Elmer model 2400 thermal cycler (Perkin-Elmer, Norwalk, CT, USA). The amplification program consisted of 1 cycle for 5 min at 94[degrees]C, 35 cycles of denaturation denaturation, term used to describe the loss of native, higher-order structure of protein molecules in solution. Most globular proteins exhibit complicated three-dimensional folding described as secondary, tertiary, and quarternary structures. at 94[degrees]C for 30 s, annealing annealing (ənēl`ĭng), process in which glass, metals, and other materials are treated to render them less brittle and more workable. at 56[degrees]C for 1 min, and extension at 72[degrees]C for 1 min. This process was followed by a final extension at 72[degrees]C for 5 min. The amplification products then underwent electrophoresis in a 2% agarose gel containing ethidium bromide and visualized trader UV light. The acute- and convalescent-phase blood samples were processed and run through the PCR instrument at the same time as the eschar specimens. DNA from reference strains of Gilliam, Karp, and Kato was used as positive controls, and distilled water was used as a negative control in each amplification. To avoid contamination, DNA extraction, reagent setup, PCR, and electrophoresis were performed in separate rooms. Sequence Analysis The purified PCR amplicons of all the positive samples were sequenced by Shanghai Invitrogen Biotechnology Co. Ltd (Shanghai, People's Republic of China). The sequences were compared with all available reported O. tsutsugamushi Sta56 gene sequences in GenBank by using BLAST (Basic Local Alignment Search Tool) program (available from www.ncbi.nlm.nih.gov/BLAST). The GenBank accession numbers of sequences obtained from the 7 patients in this study are DQ188085, DQ188086, DQ188087, DQ188088, DQ188089, DQ188090, and DQ188091, respectively. Results Seroconversion or a >4-fold rise in titers of IgG antibody to O. tsutsugamushi was observed in all 7 patients (Table), thus confirming the diagnosis of scrub typhus. Seven eschars and 7 acute-phase blood samples from the patients were positive by PCR targeting the Sta56 gene, while 7 convalescent-phase blood samples collected after antimicrobial drug treatment were all PCR-negative. The 317-bp partial sequence of the O. tsutsugamushi Sta56 gene amplified from each eschar was identical to that of its corresponding acute-phase blood sample. The sequences from the 7 patients differed from each other by 1 or 2 bp; two sequences were identical. The nucleotide sequences were 95.6%-97.8% homologous with the corresponding parts of Kawasaki strain Sta56 gene deposited in GenBank (accession no. M63383), while the sequence homologies with other strains such as Karp, Kato, Kuroki, Shimokoshi, and Je-cheon were all <75.87%. Discussion Previous studies used spleen tissues of infected mammals or acute-phase blood from patients to detect O. tsutsugamushi by PCR (3,4). However, PCR amplification of O. tsutsugamushi DNA from blood often lacks sensitivity because some hemoglobin, iron porphyrin, and other factors may inhibit the PCR, although obtaining and processing the blood that avoids the inhibitors is possible (3,4,9). Ono et al. previously found O. tsutsugamushi DNA (identified as Kawasaki type) in only 1 patient's eschar before antimicrobial drug treatment but not in the acute-phase blood sample (9). In the present study, 7 scrub typhus patients were examined, and O. tsutsugamushi DNA was successfully detected in their spontaneously desquamated eschars and acute-phase blood samples. These findings further proved that eschars could be used as an alternative, easily acquired, and sensitive sample for the diagnosis of O. tsutsugamushi infection, particularly when persons are reluctant to provide a blood sample because of cultural or other reasons. We described a new simple confirmatory diagnostic assay in which eschars are used as an alternative to serologic tests such as IFA, which usually requires double blood samples from acute and convalescent phases. In addition, from the successful and efficient detection of the O. tsutsugamushi DNA in naturally desquamated eschars, we can infer the presence of the agent in eschars before beginning antimicrobial drug therapy. If eschars had been sampled during the acute phase by punch biopsy, this method could be used for the early diagnosis of scrub typhus. A previous study carried out in Thailand detected O. tsutsugamushi DNA in convalescent-phase blood of patients after a single dose of doxycycline doxycycline /doxy·cy·cline/ (dok?se-si´klen) a semisynthetic broad-spectrum tetracycline antibiotic, active against a wide range of gram-positive and gram-negative organisms; used also as d. calcium and d. hyclate. (10). However, in the present study, O. tsutsugamushi DNA was not persistent in the convalescent-phase blood of patients after 4-5 days of chloramphenicol treatment. Whether a lack of PCR sensitivity or difference in the treatment regimens explains the apparent lack of O. tsutsugamushi DNA in the convalescent-phase blood samples is not known. A possible reason is that the patients in the present study were infected with the less virulent strain of O. tsutsugamushi (11), which may only persist in blood for a short period after antimicrobial drug treatment. Our previous study indicated that to isolate O. tsutsugamushi from patients with autumn-winter scrub typhus, cyclophosphamide cyclophosphamide /cy·clo·phos·pha·mide/ (-fos´fah-mid) a cytotoxic alkylating agent of the nitrogen mustard group; used as an antineoplastic, as an immunosuppressant to prevent transplant rejection, and to treat some diseases (0.25 mg/g of body weight) had to be injected into the experimental mice after injection of patients' blood to suppress immunity (11). Sequence analysis of partial Sta56 gene clarified that the genotypes of O. tsutsugamushi in the scrub typhus patients from Shandong Province, China, were more closely related to Kawasaki type, which is less virulent than other genotypes and only caused a mild syndrome (1). The finding has applications for physicians to treat patients and prescribe medicine. This research was supported by the National Nature and Science Foundation of the People's Republic of China (no. 30371237) and EU Project (no. SP22--CT--2004--003824). References (1.) Chen XR. Scrub typhus and Orientia tsutsugamushi. Beijing: Military Medical Science Press, 2001. p. 176-9. (2.) Wu GH. The epidemiological characteristics and prevention and cure of scrub typhus in China. Chin J Public Health. 2000;16:777-9. (3.) Guo HB, Pan SZ, Li XF, Tang JQ, Zhang Y, Wu GH. Studies on detecting and typing of Rickettsia tsutsugamushi by polymerase chain reaction. Chin J Zoon See Zune. . 1997;13:8-11. (4.) Guo HB, Tang JQ, Li XF, Pan SZ, Zhang Y, Yu MM, et al. Study on target gene of new type Rickettsia tsutsugamushi in China by PCR/RFLP and sequence analysis. Chin J Public Health. 1997;6:193-6. (5.) Ohashi N, Koyama Y, Urakami H, Fukuhara M, Tamura A, Kawamori F, et al. Demonstration of antigenic and genotypic variation of Orientia tsutsugamushi which were isolated in Japan, and their classification into type and subtype. Microbiol Immunol. 1996;40: 627-38. (6.) Furuya Y, Yoshida Y, Katayama T, Yamamoto S, Kawamura JR. Serotype-specific amplification of Rickettsia tsutsugamushi DNA by nested polymerase chain reaction Nested polymerase chain reaction is a modification of polymerase chain reaction intended to reduce the contaminations in products due to the amplification of unexpected primer binding sites. . J Clin Microbiol. 1993;31: 1637-40. (7.) Ohashi N, Nashimoto H, Ikeda H, Tamura A. Cloning and sequencing of the gene (tsg56) encoding a type-specific antigen from Rickettsia tsutsugamushi. Gene. 1990;91:119-22. (8.) Stover CK, Marana DP, Carter JM, Roe BA, Mardis E, Oaks EV. The 56-kilodation major protein antigen gene of Rickettsia tsutsugamushi: molecular cloning and sequencing analysis of the Sta56 gene and precise identification of a strain-specific epitope epitope: see immunity. . Infect Immun. 1990;58:2076-84. (9.) Ono A, Nakamura K, Hihuchi S, Miwa Y, Nakamura K, Tsunoda T, et al. Successful diagnosis using eschar for PCR specimen in tsutsugamushi disease. Intern Med. 2002;41:408-11. (10.) Saisongkorh W, Chenchittikul M, Silpapojakul K. Evaluation of nested PCR for the diagnosis of scrub typhus among patients with acute pyrexia pyrexia /py·rex·ia/ (pi-rek´se-ah) pl. pyrex´iae fever.pyrex´ial py·rex·i·a n. See fever. py·rex of unknown origin. Trans R Soc Trop Med Hyg. 2004;98:360-6. (11.) Liu YX, Zhao ZT, Gao Y, Jia CQ, Zhang JL, Yang ZQ, et al. Characterization of Orientia tsutsugamushi strains isolated in Shandong Province, China by immunofluorescence Immunofluorescence A technique that uses a fluorochrome to indicate the occurrence of a specific antigen-antibody reaction. The fluorochrome labels either an antigen or an antibody. and restriction fragment length polymorphism restriction fragment length polymorphism n. Abbr. RFLP Intraspecies variations in the length of DNA fragments generated by the action of restriction enzymes and caused by mutations that alter the sites at which these enzymes act, changing (RFLP RFLP abbr. restriction fragment length polymorphism RFLP restriction fragment length polymorphism. RFLP ) analyses. Southeast Asian J Trop Med Public Health. 2004;35:353-7. Yun-Xi Liu, * Wu-Chun Cao, * Yuan Gao, ([dagger]) Jing-Lan Zhang, ([dagger]) Zhan-Qing Yang, ([dagger]) Zhong-Tang Zhao, ([double dagger]) and Janet E. Foley ([section]) * Beijing Institute of Microbiology and Epidemiology, Beijing, People's Republic of China; ([dagger]) Center for Disease Control and Prevention Noun 1. Center for Disease Control and Prevention - a federal agency in the Department of Health and Human Services; located in Atlanta; investigates and diagnoses and tries to control or prevent diseases (especially new and unusual diseases) CDC of Jinan, Jinan, People's Republic of China; ([double dagger]) Shandong University, Jinan, People's Republic of China; and ([section]) University of California, Davis The University of California, Davis, commonly known as UC Davis, is one of the ten campuses of the University of California, and was established as the University Farm in 1905. , Davis, California, USA Address for correspondence: Wu-Chun Cao, State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, 20 Dong-Da St, Fengtai District, Beijing 100071, People's Republic of China; email: caowc@nic.bmi.ac.cn Dr Liu is a professor of epidemiology at the Beijing Institute of Microbiology and Epidemiology. His research interests focus on vectorborne infectious diseases and highly pathogenic avian influenza.
Table. Clinical characteristics on admission and serologic
results of 7 patients with scrub typhus *
Patient Age, y Fever,
ID (sex) [degrees]C Rash
03PE1 35 (F) 38 +
03PE2 42 (M) 40 +
03PE3 48 (M) 40 +
03PE4 28 (F) 38 +
04PE5 53 (M) 38 +
04PE6 36 (M) 40 +
04PE7 31 (F) 39 +
Patient Location of
ID Lymphadenitis eschars
03PE1 + Neck
03PE2 + Umbilicus
03PE3 + Right groin
03PE4 + Left papilla
04PE5 + Waist
04PE6 + Behind right ear
04PE7 + Left axilla
Acute phase
Blood samples
Patient collected, IgG titers
ID d after onset of sera
03PE1 3 N
03PE2 7 80
03PE3 5 N
03PE4 8 160
04PE5 2 N
04PE6 10 80
04PE7 7 N
Convalescent phase
Eschars and blood
samples collected,
Patient ([dagger]) IgG titers
ID d after onset of sera
03PE1 9 320
03PE2 8 320
03PE3 10 320
03PE4 11 640
04PE5 6 320
04PE6 15 1,280
04PE7 9 640
* F, female; M, male; Ig, immunoglobulin, N, negative.
([dagger]) Chloramphenicol was given to a patient immediately
after the acute-phase blood was collected.
|
|
||||||||||||||||||||

Printer friendly
Cite/link
Email
Feedback
Reader Opinion